Failure to Vaccinate Medicare Inpatients
Authors:
- Dale W. BratzlerDBDale W. Bratzler
- Peter M. HouckPHPeter M. Houck
- Hui JiangHJHui Jiang
- Wato NsaWNWato Nsa
- Claudette ShookCSClaudette Shook
- Lori MooreLMLori Moore
- Lisa RedLRLisa Red
Open Access
- 11 November 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (20) , 2349-2356
Abstract
INFLUENZA AND PNEUMOCOCCAL vaccines are underutilized for Americans 65 years and older. Based on the 1999 Behavioral Risk Factor Surveillance System (BRFSS) survey, 66.9% received the influenza vaccine during the previous 12 months and 54.1% had ever received the pneumococcal vaccine.1 This underutilization is not without consequences. Influenza causes more than 100 000 excess hospitalizations and 20 000 deaths each year.2 Infection due to Streptococcus pneumoniae accounts for at least 500 000 cases of pneumonia and 50 000 cases of bacteremia in the United States each year.3-6 The combined reporting category of influenza and pneumonia represents the fifth leading cause of death for this age group.7Keywords
This publication has 27 references indexed in Scilit:
- A Computerized Reminder System to Increase the Use of Preventive Care for Hospitalized PatientsNew England Journal of Medicine, 2001
- Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998Opportunities for Prevention in the Conjugate Vaccine EraJAMA, 2001
- Quality of Medical Care Delivered to Medicare Beneficiaries: A Profile at State and National Levels. Jencks SF, Cuerdon T, Burwen DR, et al. JAMA 2000;284:1670–6ACC Current Journal Review, 2001
- Lack of effect of a pneumonia clinical pathway on hospital-based pneumococcal vaccination ratesThe American Journal of Medicine, 2001
- Barriers to influenza immunization in a low-income urban populationAmerican Journal of Preventive Medicine, 2001
- The Health and Economic Benefits of Influenza Vaccination for Healthy and At-Risk Persons Aged 65 to 74 YearsPharmacoEconomics, 1999
- Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior CitizensArchives of internal medicine (1960), 1998
- Factors associated with influenza and pneumococcal vaccination behavior among high-risk adultsJournal of General Internal Medicine, 1996
- The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the CommunityNew England Journal of Medicine, 1994
- Influenza Vaccine Effectiveness in Preventing Hospitalization for Pneumonia in the ElderlyAmerican Journal of Epidemiology, 1992